Nebula is free while in beta — browse the evidence map with no account.Open Nebula →
AEaH.aiEvidence · Intelligence

trial · primary record

D-BACE in combination with chemotherapy and karelizumab

NSCLC (Non-small Cell Lung Cancer)

PhasePhase 2
StatusRECRUITING
SponsorUnknown
Enrolment46
Primary completion2027-12-22
Primary endpointEvaluation of the MPR of resectable II-IIIA or potentially resectable T3-4N2 stage IIIB NSCLC treated with D-BACE in combination with chemotherapy and camrelizumab
Registry IDNCT07016126

Provenance

  • Source: ClinicalTrials.gov
  • Fetched at: 2026-10-28T03:27:18.255Z
  • Licence class: attribution-required
  • Verdict: primary-source
  • Entity id: NCT07016126

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Start monitoring — $199/monthAll trial records
D-BACE in combination with chemotherapy and karelizumab — trial | AEaH